封面
市场调查报告书
商品编码
1770839

无标记阵列系统市场-全球产业规模、份额、趋势、竞争、机会和预测,按类型、应用、最终用户、地区和竞争细分,2020-2030 年

Label-free Array Systems Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Type, By Application, By End user, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球无标记阵列系统市场价值为 5.3026 亿美元,预计到 2030 年将达到 8.1411 亿美元,预测期内复合年增长率为 7.41%。无标记阵列系统是一种先进的分析工具,无需萤光或放射性标记即可识别和定量生物分子。这些系统主要基于表面等离子体共振 (SPR) 原理,透过反射光的变化即时监测生物分子相互作用。个人化医疗、快速药物开发、生物标记发现和特定蛋白质识别的需求日益增长,推动了无标记技术在研究和药物发现中的应用。它们能够对复杂的生物样本进行动态、准确的分析,使其成为现代生物医学研究中不可或缺的工具。

市场概览
预测期 2026-2030
2024年市场规模 5.3026亿美元
2030年市场规模 8.1411亿美元
2025-2030 年复合年增长率 7.41%
成长最快的领域 合约研究组织(CRO)
最大的市场 北美洲

关键市场驱动因素

药物研发中对即时、高通量分析的需求日益增长

主要市场挑战

设备成本高且基础设施需求高

主要市场趋势

与人工智慧和机器学习整合以进行数据解释

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球无标记阵列系统市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型(表面电浆共振、生物层干涉法、细胞介电光谱法等)
    • 按应用(药物发现、蛋白质界面分析、抗体表征等)
    • 按最终用户(製药和生物技术公司、学术和研究机构、合约研究组织等)
    • 按公司分类(2024)
    • 按地区
  • 市场地图

第六章:亚太地区无标记阵列系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第七章:欧洲无标记阵列系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章:北美无标记阵列系统市场展望。

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第九章:南美洲无标记阵列系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲无标记阵列系统市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 併购
  • 产品开发

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品/服务的威胁

第 14 章:无标记阵列系统市场:SWOT 分析

第 15 章:竞争格局

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Sartorius AG

第 16 章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 15121

The Global Label-free Array Systems Market was valued at USD 530.26 million in 2024 and is projected to reach USD 814.11 million by 2030, growing at a CAGR of 7.41% during the forecast period. Label-free array systems are advanced analytical tools used for identifying and quantifying biomolecules without the need for fluorescent or radioactive labels. These systems operate primarily on the principle of Surface Plasmon Resonance (SPR), enabling real-time monitoring of biomolecular interactions through changes in reflected light. Increasing demand for personalized medicine, rapid drug development, biomarker discovery, and specific protein identification is driving the adoption of label-free technologies in research and drug discovery. Their ability to deliver dynamic, accurate analysis in complex biological samples positions them as indispensable tools in modern biomedical research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 530.26 Million
Market Size 2030USD 814.11 Million
CAGR 2025-20307.41%
Fastest Growing SegmentContract Research Organizations (CROs)
Largest MarketNorth America

Key Market Drivers

Increasing Demand for Real-Time, High-Throughput Analysis in Drug Discovery

The rising need for real-time, high-throughput screening technologies in pharmaceutical and biotechnological research is a major driver of the label-free array systems market. Traditional labeled assays are time-intensive and susceptible to inaccuracies due to interference from the labels themselves. Label-free array systems overcome these limitations by allowing direct observation of biomolecular interactions without tagging, providing valuable kinetic data. This is especially critical in early drug discovery stages where understanding drug-target affinities and interaction profiles can guide lead compound selection and optimization, significantly accelerating the development pipeline.

Key Market Challenges

High Cost of Equipment and Infrastructure Requirements

Despite offering cutting-edge capabilities, label-free array systems come with high capital and operational costs. The instruments often require specialized detection components-optical, acoustic, or electrochemical-which demand substantial financial investment and maintenance. Moreover, these systems frequently need controlled lab environments such as clean rooms or vibration-free setups, further increasing infrastructure costs. These financial constraints can hinder adoption in small- to mid-sized research facilities and institutions, particularly in low- and middle-income regions. Even in developed countries, funding limitations pose challenges for academia and SMEs unless supported by grants or partnerships, which remain competitive and limited in availability.

Key Market Trends

Integration with Artificial Intelligence and Machine Learning for Data Interpretation

The incorporation of artificial intelligence (AI) and machine learning (ML) technologies into label-free array systems is transforming how large-scale biological data is analyzed. These systems produce vast and complex datasets, particularly in proteomics and biomarker discovery. AI-driven analytics streamline data processing by detecting subtle patterns, improving signal clarity, and reducing background noise. This trend enhances both the accuracy and speed of research outputs. Globally, regulatory and research bodies are promoting AI integration in healthcare. The FDA's Digital Health Center of Excellence and the European Commission's Digital Europe Programme-with a €7.5 billion allocation-are key initiatives advancing AI-based biomedical innovation, supporting broader adoption of intelligent data analytics in label-free platforms.

Key Market Players

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Sartorius AG

Report Scope:

In this report, the Global Label-free Array Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Label-free Array Systems Market, By Type:

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Cellular Dielectric Spectroscopy
  • Others

Label-free Array Systems Market, By Application:

  • Drug Discovery
  • Protein Interface Analysis
  • Antibody Characterization
  • Others

Label-free Array Systems Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute
  • Contract Research Organization
  • Others
  • Ambulatory Care Centers
  • Others

Label-free Array Systems Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Label-free Array Systems Market.

Available Customizations:

Global Label-free Array Systems Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-free Array Systems Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others)
    • 5.2.2. By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others)
    • 5.2.3. By End user (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. Asia-Pacific Label-free Array Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Label-free Array Systems Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End user
    • 6.3.2. India Label-free Array Systems Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End user
    • 6.3.3. South Korea Label-free Array Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End user
    • 6.3.4. Japan Label-free Array Systems Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End user
    • 6.3.5. Australia Label-free Array Systems Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End user

7. Europe Label-free Array Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Label-free Array Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End user
    • 7.3.2. Germany Label-free Array Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Label-free Array Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Label-free Array Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Label-free Array Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End user

8. North America Label-free Array Systems Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Label-free Array Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End user
    • 8.3.2. Mexico Label-free Array Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End user
    • 8.3.3. Canada Label-free Array Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End user

9. South America Label-free Array Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Label-free Array Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End user
    • 9.3.2. Argentina Label-free Array Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End user
    • 9.3.3. Colombia Label-free Array Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End user

10. Middle East and Africa Label-free Array Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Label-free Array Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End user
    • 10.3.2. Saudi Arabia Label-free Array Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End user
    • 10.3.3. UAE Label-free Array Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Label-free Array Systems Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Illumina, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. PerkinElmer, Inc.
  • 15.5. Merck KGaA
  • 15.6. Danaher Corporation
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. F. Hoffmann-La Roche Ltd.
  • 15.9. Becton, Dickinson and Company
  • 15.10. Sartorius AG

16. Strategic Recommendations

17. About Us & Disclaimer